Chronic oral epigallocatechin-gallate alleviates streptozotocin-induced diabetic neuropathic hyperalgesia in rat: Involvement of oxidative stress

Iranian Journal of Pharmaceutical Research

Volumn 11, Issue 4, 2012, Pages 1243-1253

  Baluchnejadmojarad, Tourandokht ^a   Roghani, Mehrdad ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHED UNIVERSITY   (Iran)

Author keywords

Diabetic rat; Epigallocatechin 3 gallate; Hyperalgesia; Oxidative stress

Indexed keywords

EPIGALLOCATECHIN GALLATE; NITRITE; STREPTOZOCIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETIC NEUROPATHY; EXPERIMENTAL TEST; GLUCOSE BLOOD LEVEL; HOT TAIL IMMERSION TEST; HYPERALGESIA; MALE; NONHUMAN; OXIDATIVE STRESS; PAW PRESSURE TEST; RAT; VOCALIZATION;

EID: 84871355903     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Wild S, Roglic G, Green A, Sicree R and King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. (2004) Diabetes Care 27: 1047-1053.
2. Sima AA and Sugimoto K. Experimental diabetic neuropathy: an update. Diabetologia (1999) 42: 773-788.
3. Van Dam PS. Oxidative stress and diabetic neuropathy: pathophysiological mechanisms and treatment perspectives. Diabetes Metab. Res. Rev. (2002) 18: 176-184.
4. Obrosova IG. Update on the pathogenesis of diabetic neuropathy. Curr. Diab. Rep. (2003) 3: 439-445.
5. Vincent AM, Russell JW, Low P and Feldman EL. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr. Rev. (2004) 25: 612-628.
6. Nickander KK, McPhee BR, Low PA and Tritschler H. Alpha-lipoic acid: antioxidant potency against lipid peroxidation of neural tissues in-vitro and implications for diabetic neuropathy. Free Radic. Biol. Med. (1996) 21: 631-639.
7. Cameron NE and Cotter MA. Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes. Diabetes Res. Clin. Pract. (1999) 45: 137-146.
8. Laight DW, Carrier MJ and Anggard EE. Antioxidants, diabetes and endothelial dysfunction. Cardiovasc. Res. (2000) 47: 457-464.
9. Machha A and Mustafa MR. Chronic treatment with flavonoids prevents endothelial dysfunction in spontaneously hypertensive rat aorta. J. Cardiovasc. Pharmacol. (2005) 46: 36-40.
10. Chu JX, Wang AL and Han SHY. The Effects of total flavonoids from buckwheat flowers and leaves on renal damage and PTP1B expression in type 2 diabetic rats. Iranian J. Pharm. Res. (2011) 10: 511-517.
11. Yang CS, Chen L, Lee MJ, Balentine D, Kuo MC and Schantz S P. Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol. Biomarkers Prev. (1998) 7: 351-354.
12. Guo Q, Zhao B, Li M, Shen S and Xin W. Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes. Biochim. Biophys. Acta (1996) 1304: 210-222.
13. Fu Z, Zhen W, Yuskavage J and Liu D. Epigallocatechin gallate delays the onset of type 1 diabetes in spontaneous non-obese diabetic mice. Br. J. Nutr. (2011) 105: 1218-1225.
14. Roghani M and Baluchnejadmojarad T. Hypoglycemic and hypolipidemic effect and antioxidant activity of chronic epigallocatechin-gallate in streptozotocin-diabetic rats. Pathophysiol. (2010) 17: 55-59.
15. Kang KS, Wen Y, Yamabe N, Fukui M, Bishop SC and Zhu BT. Dual beneficial effects of (-)-epigallocatechin-3-gallate on levodopa methylation and hippocampal neurodegeneration: in-vitro and in-vivo studies. PLoSOne (2010) 5: e11951.
16. Mandel SA, Amit T, Weinreb O, Reznichenko L and Youdim MB. Simultaneous manipulation of multiple brain targets by green tea catechins: a potential neuroprotective strategy for Alzheimer and Parkinson diseases. CNS Neurosci. Ther. (2008) 14: 352-365.
17. Weinreb O, Amit T, Mandel S and Youdim MB. Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a refective outcome of its antioxidant, iron chelating and neuritogenic properties. Genes Nutr. (2009) 4: 283-296.
18. Mandel S, Einreb O, Amit T and Youdim MB. Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3-gallate: implications for neurodegenerative diseases. J. Neurochem. (2004) 88: 1555-15569.
19. Cho HS, Kim S, Lee SY, Park JA, Kim SJ and Chun HS. Protective effect of the green tea component, L-theanine on environmental toxins-induced neuronal cell death. Neurotoxicol. (2008) 29: 656-662.
20. Zhang B, Rusciano D and Osborne NN. Orally administered epigallocatechin gallate attenuates retinal neuronal death in-vivo and light-induced apoptosis in-vitro. Brain Res. (2008) 1198: 141-152.
21. Antonio AM and Druse MJ. Antioxidants prevent ethanol-associated apoptosis in fetal rhombencephalic neurons. Brain Res. (2008) 1204: 16-23.
22. Hong JT, Ryu SR, Kim HJ, Lee JK, Lee SH, Kim DB, Yun YP, Ryu JH, Lee BM and Kim PY. Neuroprotective effect of green tea extract in experimental ischemiareperfusion brain injury. Brain Res. Bull. (2000) 53: 743-749.
23. Hong JT, Ryu SR, Kim HJ, Lee JK, Lee SH, Yun YP, Lee BM and Kim PY. Protective effect of green tea extract on ischemia/reperfusion-induced brain injury in Mongolian gerbils. Brain Res. (2001) 88: 11-18.
24. Kumar P and Kumar A. Effect of lycopene and epigallocatechin-3-gallate against 3-nitropropionic acid induced cognitive dysfunction and glutathione depletion in rat: a novel nitric oxide mechanism. Food Chem. Toxicol. (2009) 47: 2522-2530.
25. Rezai-Zadeh K, Shytle D, Sun N, Mori T, Hou H and Jeanniton D. Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J. Neurosci. (2005) 25: 8807-8814.
26. Dubuisson D and Dennis SG. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine and brain stem stimulation in rats and cats. Pain (1977) 4: 161-174.
27. Courteix C, Eschalier A and Lavarenne J. Streptozotocin-induced diabetic rats: behavioral evidence for a model of chronic pain. Pain (1993) 53: 81-88.
28. Randall LO and Selitto JJ. A method for measurement of analgesic activity on inflamed tissue. Arch. Int. Pharmacodyn. Ther. (1957) 111: 409-419.
29. Baluchnejadmojarad T, Roghani M and Khastehkhodaie Z. Chronic treatment of silymarin improves hyperalgesia and motor nerve conduction velocity in diabetic neuropathic rat. Phytother Res. (2010) 24: 1120-1125.
30. Roghani M and Baluchnejadmojarad T. Chronic epigallocatechin-gallate improves aortic reactivity of diabetic rats: underlying mechanisms. Vascul. Pharmacol. (2009) 51: 84-89.
31. Freshwater JD, Svensson CI, Malmberg AB and Calcutt NA. Elevated spinal cyclooxygenase and prostaglandin release during hyperalgesia in diabetic rats. Diabetes (2002) 51: 2249-2255.
32. Fox A, Eastwood C, Gentry C, Manning D and Urban L. Critical evaluation of the streptozotocin model of painful diabetic neuropathy in the rat. Pain (1999) 81: 307-316.
33. Dobretsov M, Hastings SL, Stimers JR and Zhang JM. Mechanical hyperalgesia in rats with chronic perfusion of lumbar dorsal root ganglion with hyperglycemic solution. J. Neurosci. Methods (2001) 110: 9-15.
34. Malcangio M and Tomlinson DR. A pharmacologic analysis of mechanical hyperalgesia in streptozotocin-diabetic rats. Pain (1998) 76: 151-157.
35. Sasaki T, Yasuda H, Maeda K and Kikkawa R. Hyperalgesia and decreased neuronal nitric oxide synthase in diabetic rats. Neuroreport (1998) 9: 243-247.
36. Rutledge LP, Ngong JM, Kuperberg JM, Samaan SS, Soliman KF and Kolta MG. Dopaminergic system modulation of nociceptive response in long-term diabetic rats. Pharmacol. Biochem. Behav. (2002) 74: 1-9.
37. 2+ channels in attenuated morphine antinociception in streptozotocin-diabetic rats. Eur. J. Pharmacol. (2002) 435: 187-194.
38. Shibata M, Ohkubo T, Takahashi H and Inoki R. Modified formalin test: characteristic biphasic pain response. Pain (1989) 38: 347-352.
39. Rosland JH, Tjolsen A, Maehle B and Hole K. The formalin test in mice-effect of formalin concentration. Pain (1990) 42: 235-242.
40. Waltner-Law ME, Wang XL, Law BK, Hall RK, Nawano M, Granner DK. Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production, J. Biol. Chem. (2002) 277: 34933-34940.
41. Koyama Y, Abe K, Sano Y, Ishizaki Y, Njelekela M, Shoji Y, Hara Y and Isemura M. Effects of green tea on gene expression of hepatic gluconeogenic enzymes in-vivo. Planta Med. (2004) 70:1100-1102.
42. Collins QF, Liu HY, Pi J, Liu Z, Quon MJ and Cao W. Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5-AMP-activated protein kinase. J. Biol. Chem. (2007) 282: 30143-30149.
43. Toleikis PM and Godin DV. Alteration of antioxidant status in diabetic rats by chronic exposure to psychological stressors. Pharmacol. Biochem. Behav. (1995) 52: 355-366.
44. Sen CK. Oxygen toxicity and antioxidants: state of the art. Indian J. Physiol. Pharmacol. (1995) 39: 177-196.
45. Coppey LJ, Gellett JS, Davidson EP, Dunlap JA and Yorek MA. Effect of treating streptozotocin-induced diabetic rats with sorbinil, myo-inositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve. Int. J. Exp. Diabetes Res. (2002) 3: 21-36.
46. Higdon JV and Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit. Rev. Food Sci. Nutr. (2003) 43: 89-143.
47. Hasegawa M. Biochemistry and molecular biology of tauopathies. Neuropathology (2006) 26:484-490.
48. Kondo K, Kurihara M, Miyata N, Suzuki T and Toyoda M: Scavenging mechanisms of (-)-epigallocatechin gallate and (-)-epicatechin gallate on peroxyl radicals and formation of superoxide during the inhibitory action. Free Radic. Biol. Med. (1999) 27:855-863.
49. Guo Q, Zhao B, Li M, Shen S and Xin W. Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes. Biochim. Biophys. Acta (1996) 1304:210-222.
50. Van Acker SA, Tromp MN, Haenen GR, van DV and Bast A. Flavonoids as scavengers of nitric oxide radical. Biochem. Biophys. Res. Commun. (1995) 214: 755-759.
51. Lin YL and Lin JK. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB. Mol. Pharmacol. (1997) 52: 465-472.
52. Chan MM, Fong D, Ho CT and Huang HI. Inhibition of inducible nitric oxide synthase gene expression and enzyme activity by epigallocatechin gallate, a natural product from green tea. Biochem. Pharmacol. (1997) 54: 1281-1286.
53. Patil L and Balaraman R. Effect of Green Tea Extract on Doxorubicin Induced Cardiovascular Abnormalities: Antioxidant Action. Iranian J. Pharm. Res. (2011) 10: 89-96.
54. Sano M, Takahashi Y, Yoshino K, Shimoi K, Nakamura Y and Tomita I. Effect of tea (Camellia sinensis L.) on lipid peroxidation in rat liver and kidney: a comparison of green and black tea feeding. Biol. Pharm. Bull. (1995) 18: 1006-1008.